Susquehanna Fundamental Investments’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-13,790
Closed -$11K 1253
2022
Q3
$11K Buy
+13,790
New +$11K ﹤0.01% 1416
2022
Q1
$23K Buy
+13,790
New +$23K ﹤0.01% 1510
2021
Q1
Sell
-42,452
Closed -$151K 1544
2020
Q4
$151K Sell
42,452
-11,676
-22% -$41.5K ﹤0.01% 1393
2020
Q3
$217K Buy
+54,128
New +$217K 0.01% 1171